{"altmetric_id":21871620,"counts":{"readers":{"mendeley":7,"citeulike":0,"connotea":0},"total":{"posts_count":2},"twitter":{"unique_users_count":2,"unique_users":["ShinHiroi","hidenoi28"],"posts_count":2}},"citation":{"altmetric_jid":"4f6fa6313cf058f610008428","authors":["Galina Perel","Joshua Bliss","Christan M. Thomas"],"first_seen_on":"2017-07-14T01:39:38+00:00","issns":["1052-1372"],"issue":"5","journal":"P & T","last_mentioned_on":1502588296,"links":["https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4849338\/"],"pmcid":"PMC4849338","pmid":"27162470","pubdate":"2016-05-01T00:00:00+00:00","publisher":"MediMedia, USA","publisher_subjects":[{"name":"Pharmacology And Pharmaceutical Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"303","title":"Carfilzomib (Kyprolis): A Novel Proteasome Inhibitor for Relapsed And\/or Refractory Multiple Myeloma.","type":"article","volume":"41","mendeley_url":"http:\/\/www.mendeley.com\/research\/carfilzomib-kyprolis-novel-proteasome-inhibitor-relapsed-andor-refractory-multiple-myeloma"},"altmetric_score":{"score":1.35,"score_history":{"1y":1.35,"6m":1.35,"3m":1.35,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1.35},"context_for_score":{"all":{"total_number_of_other_articles":8366012,"mean":7.0543497525808,"rank":4154280,"this_scored_higher_than_pct":49,"this_scored_higher_than":4147758,"rank_type":"exact","sample_size":8366012,"percentile":49},"similar_age_3m":{"total_number_of_other_articles":226616,"mean":12.826333543675,"rank":112670,"this_scored_higher_than_pct":49,"this_scored_higher_than":111595,"rank_type":"exact","sample_size":226616,"percentile":49},"this_journal":{"total_number_of_other_articles":261,"mean":15.661346153846,"rank":154,"this_scored_higher_than_pct":40,"this_scored_higher_than":105,"rank_type":"exact","sample_size":261,"percentile":40},"similar_age_this_journal_3m":{"total_number_of_other_articles":5,"mean":3.475,"rank":3,"this_scored_higher_than_pct":40,"this_scored_higher_than":2,"rank_type":"exact","sample_size":5,"percentile":40}}},"demographics":{"poster_types":{"member_of_the_public":2},"users":{"twitter":{"cohorts":{"Members of the public":2}},"mendeley":{"by_status":{"Student  > Ph. D. Student":1,"Student  > Postgraduate":1,"Other":1,"Student  > Bachelor":3,"Professor":1},"by_discipline":{"Medicine and Dentistry":4,"Agricultural and Biological Sciences":1,"Unspecified":2}}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/ShinHiroi\/statuses\/885675066242945028","license":"gnip","citation_ids":[21871620],"posted_on":"2017-07-14T01:39:25+00:00","author":{"name":"\u65b0\u85ac\u305f\u3093","image":"https:\/\/pbs.twimg.com\/profile_images\/627672921687744512\/rm2eDI4t_normal.jpg","description":"\u5e83\u3044\u4e16\u754c\u304b\u3089\u65b0\u85ac\u3092\u3054\u7d39\u4ecb\u3057\u307e\u3059\n(\u514d\u8cac\u4e8b\u9805\uff09\u5f53\u8a18\u4e8b\u306f\u6b63\u78ba\u6027\u3092\u5fc3\u639b\u3051\u3066\u304a\u308a\u307e\u3059\u304c\u3001\u500b\u4eba\u306e\u610f\u898b\u3067\u3042\u308a\u3001\u533b\u5b66\u7684\u306a\u59a5\u5f53\u6027\u3092\u5b8c\u5168\u306b\u4fdd\u8a3c\u3059\u308b\u3082\u306e\u3067\u306f\u306a\u3044\u3053\u3068\u306b\u3054\u7559\u610f\u4e0b\u3055\u3044","id_on_source":"ShinHiroi","tweeter_id":"838105746","geo":{"lt":null,"ln":null},"followers":2379},"tweet_id":"885675066242945028"},{"url":"http:\/\/twitter.com\/hidenoi28\/statuses\/896546412631998464","license":"gnip","rt":["ShinHiroi"],"citation_ids":[21871620],"posted_on":"2017-08-13T01:38:16+00:00","author":{"name":"hidenoi28@\u591a\u767a\u6027\u9aa8\u9ac4\u816b@\u304c\u3093","image":"https:\/\/pbs.twimg.com\/profile_images\/896475784877031425\/fxXwLkR6_normal.jpg","description":"\u591a\u767a\u6027\u9aa8\u9ac4\u816b \u304c\u3093 2017\/08\/01  BJP-\u03b3\u578b D&S 3B ISS2\u671f   \u514d\u75ab\u96fb\u6c17\u6cf3\u52d5  BJP-IgM \u9aa8\u9ac4\u816b D&S 3B ISS2\u671f \u9aa8\u9ac4\u816b 55%","id_on_source":"hidenoi28","tweeter_id":"896471467470147584","geo":{"lt":null,"ln":null},"followers":0},"tweet_id":"896546412631998464"}]}}